Summary from the original article
The FDA announced that GLP-1 weight loss drugs will now include warning labels indicating a potential increased risk of vision loss.
AI key points, how left, center and right framed this story, tone by side and loaded language are part of News.gg Premium.
Upgrade this serverThe FDA announced that GLP-1 weight loss drugs will now include warning labels indicating a potential increased risk of vision loss.
2 days ago · cbsnews.com · You are reading this one